Market closed
AtriCure/$ATRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AtriCure
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Ticker
$ATRC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,300
Website
AtriCure Metrics
BasicAdvanced
$1.5B
-
-$0.81
1.65
-
Price and volume
Market cap
$1.5B
Beta
1.65
52-week high
$43.11
52-week low
$18.94
Average daily volume
676K
Financial strength
Current ratio
4.108
Quick ratio
2.666
Long term debt to equity
16.403
Total debt to equity
17.028
Interest coverage (TTM)
-5.70%
Management effectiveness
Return on assets (TTM)
-3.70%
Return on equity (TTM)
-8.38%
Valuation
Price to revenue (TTM)
2.976
Price to book
3.3
Price to tangible book (TTM)
9.07
Price to free cash flow (TTM)
-2,125.973
Growth
Revenue change (TTM)
15.79%
Earnings per share change (TTM)
1.08%
3-year revenue growth (CAGR)
18.35%
3-year earnings per share growth (CAGR)
-10.39%
What the Analysts think about AtriCure
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for AtriCure stock.
AtriCure Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AtriCure Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AtriCure News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for AtriCure stock?
AtriCure (ATRC) has a market cap of $1.5B as of May 09, 2025.
What is the P/E ratio for AtriCure stock?
The price to earnings (P/E) ratio for AtriCure (ATRC) stock is 0 as of May 09, 2025.
Does AtriCure stock pay dividends?
No, AtriCure (ATRC) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next AtriCure dividend payment date?
AtriCure (ATRC) stock does not pay dividends to its shareholders.
What is the beta indicator for AtriCure?
AtriCure (ATRC) has a beta rating of 1.65. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.